Sign In
Free Newsletter
Report: NJ expands life sciences leadership
New Jersey expands its life sciences leadership with biotech growth, new biomanufacturing space and innovation investments.
Novartis reports progress on $23B US manufacturing expansion
Novartis advances its $23B U.S. manufacturing plan, expanding R&D and drug production as it aims to produce key medicines domestically.
BioNJ dinner honors life sciences leaders, Sherrill keynotes
Gov. Mikie Sherrill delivered the keynote at the annual event, which highlighted awards, breakthroughs and industry innovators.
FDA approves Novartis’ Itvisma gene therapy for SMA
The treatment is the first of its kind for spinal muscular atrophy patients age 2 and older, offering a one-time injection option.
Rocket Pharmaceuticals to cut 30% of workforce
The Cranbury-based biotechnology company will eliminate 80 jobs and streamline operations, focusing on gene therapies to extend its runway into Q2 2027 and drive long-term growth.
Pierre Fabre USA makes in-state HQ move to Secaucus
Pierre Fabre Laboratories relocated its stateside base from Parsippany to expand its dermo-cosmetics, rare disease and oncology efforts while staying rooted in New Jersey.
PTC Therapeutics to lay off 308 employees in Hopewell
As a result of the cuts, which represent 25% of the biotech's workforce, the company expects to see a 20% reduction in annualized operating expenses.
